TheraRadar
Data updated: Jun 17, 2026

WESTCORT (hydrocortisone valerate)

Dermatology Approved 1978-03-17
2
Indications
--
Phase 3 Trials
48
Years on Market

Details

Status
Discontinued
First Approved
1978-03-17
Routes
TOPICAL
Dosage Forms
CREAM, OINTMENT

Companies

Active Ingredient: HYDROCORTISONE VALERATE

WESTCORT Approval History

1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
28 FDA actions from 1978 to 2003
Mar 2003 SUPPL
Label · Labeling
Sep 2002 SUPPL
Label · Labeling
Feb 1993 SUPPL
Mfg · Manufacturing (CMC)

What WESTCORT Treats

2 FDA approvals

Originally approved for its first indication in 1978 . Covers 2 distinct patient populations.

  • Other (2)

Sun Pharma's other novel FDA approvals

Other CDER-designated drugs from the same sponsor (2016–2025).

🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

WESTCORT FDA Label Details

Track WESTCORT with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.